Quick Takeaways
- Blue Owl Capital Holdings LP filed SCHEDULE 13G/A for Larimar Therapeutics, Inc. Common Stock, par value $0.001 per share (LRMR).
- Disclosed ownership: 10%.
- Date of event: 31 Dec 2025.
Blue Owl Capital Holdings LP - 31 Dec 2025 SCHEDULE 13G/A Report for Larimar Therapeutics, Inc. Common Stock, par value $0.001 per share (LRMR)
- Filing Manager
- Blue Owl Capital Holdings LP
- Reporting Manager
- Blue Owl Capital Holdings LP
- Symbol
- LRMR
- Shares outstanding
- 84,731,361 shares
- Disclosed Ownership
- 8,464,663 shares
- Ownership
- 10%
- Form type
- SCHEDULE 13G/A
- Filing time
- 12 Feb 2026, 16:36:35 UTC
- Date of event
- 31 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Blue Owl Capital Holdings LP disclosed 10% ownership in Larimar Therapeutics, Inc. Common Stock, par value $0.001 per share (LRMR) on 31 Dec 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 12 Feb 2026, 16:36.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Blue Owl Capital Holdings LP | 10% | 8,464,663 | 8,464,663 | 0 | /s/ Karen Hager | Karen Hager / Chief Compliance Officer |